Imaging Biomarkers in Preclinical and Symptomatic AD

Recruiting

Imaging Biomarkers in Preclinical and Symptomatic ADImaging Biomarkers in Preclinical and Symptomatic AD

Sponsor:

Tammie L. S. Benzinger, MD, PhD

Code:

NCT04134923

Conditions

Alzheimer Disease

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

[11C] Pittsburgh Compound-B (PIB)

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information

Trial information was received from ClinicalTrials.gov and was last updated on 2025-03-28. This information was provided to ClinicalTrials.gov by Tammie L. S. Benzinger, MD, PhD on 2024-01-17.